Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways
- 1 November 2002
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 109 (1-3) , 83-88
- https://doi.org/10.1016/s0167-0115(02)00190-8
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 28 references indexed in Scilit:
- BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neuronsNeuroReport, 2001
- Delayed Systemic Administration of PACAP38 Is Neuroprotective in Transient Middle Cerebral Artery Occlusion in the RatStroke, 2000
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Induction of DNA Fragmentation After 10 to 120 Minutes of Focal Cerebral Ischemia in RatsStroke, 1995
- PACAP Functions as a Neurotrophic FactoraAnnals of the New York Academy of Sciences, 1994
- 38‐Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cellsJournal of Neuroscience Research, 1993
- Global Cerebral Ischemia Associated with Cardiac Arrest in the Rat: I. Dynamics of Early Neuronal ChangesJournal of Cerebral Blood Flow & Metabolism, 1992
- Delayed neuronal death in the gerbil hippocampus following ischemiaBrain Research, 1982
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982
- A new model of bilateral hemispheric ischemia in the unanesthetized rat.Stroke, 1979